People under the age of 40 will be offered an alternative vaccine to the AstraZeneca/Oxford jab, according to the JCVI. The decision took into account links to rare blood clots, as well as low levels of coronavirus in the country and a greater supply of alternative vaccines. The announcement was made at a press conference led by Jonathan Van-Tam, who was joined by Dr June Raine and Professor Wei Shen Lim.
Dr Raine, from the Medicines & Healthcare products Regulatory Agency (MHRA), said that had been 242 clotting cases following 28.5 million doses of the vaccine.
In the wake of dropping infection rates, Government health advisors suggested a more precautionary approach can now be taken in those aged 30 to 39-year-olds.
This means that those under 40 will be offered the Pfizer/BioNTech or Moderna shots when available.
Prof Wei Shen Lim, from the Joint Committee on Vaccination and Immunisation (JCVI), said: “Safety remains our number one priority.
“As Covid-19 rates continue to come under control, we are advising that adults aged 18 – 39 years with no underlying health conditions are offered an alternative to the Oxford/AstraZeneca vaccine, if available, and if it does not cause delays in having the vaccine.”
MORE TO FOLLOW…